Results 81 to 90 of about 1,349,663 (338)

Tumor and germline testing with next generation sequencing in epithelial ovarian cancer: a prospective paired comparison using an 18‐gene panel

Molecular Oncology, EarlyView.
Genetic testing in epithelial ovarian cancer includes both germline and tumor‐testing. This approach often duplicates resources. The current prospective study assessed the feasibility of tumor‐first multigene testing by comparing tumor tissue with germline testing of peripheral blood using an 18‐gene NGS panel in 106 patients.
Elisabeth Spenard, Cristina Mitric, Melanie Care, Tracy L. Stockley, Raymond H. Kim, Jeanna McCuaig, Blaise Clarke, Laura Ranich, Clare Sheen, Sarah E. Ferguson, Liat Hogen, Taymaa May, Marcus Q. Bernardini   +12 more
wiley   +1 more source

Cost-effectiveness of counseling and pedometer use to increase physical activity in the Netherlands: a modeling study

Cost Effectiveness and Resource Allocation, 2012
Background Counseling in combination with pedometer use has proven to be effective in increasing physical activity and improving health outcomes. We investigated the cost-effectiveness of this intervention targeted at one million insufficiently active ...
Over Eelco AB, Wendel-Vos GC, van den Berg Matthijs, Reenen Heleen H, Tariq Luqman, Hoogenveen Rudolf T, van Baal Pieter HM   +6 more
doaj   +1 more source

Using cost-effectiveness analyses to inform policy: the case of antiretroviral therapy in Thailand. [PDF]

, 2006
BACKGROUND: Much emphasis is put on providing evidence to assist policymakers in priority setting and investment decisions. Assessing the cost-effectiveness of interventions is one technique used by policymakers in their decisions around the allocation ...
Tantivess, Sripen, Walt, Gill
core   +2 more sources

Cost-Effectiveness Evaluation of Nearly Zero-Energy Buildings for the Aging of Red Wine [PDF]

, 2021
María Teresa Gómez-Villarino, María del Mar Barbero–Barrera, Fernando R. Mazarrón, Ignacio Cañas Guerrero   +3 more
openalex   +1 more source

Screening for lung cancer: A systematic review of overdiagnosis and its implications

Molecular Oncology, EarlyView.
Low‐dose computed tomography (CT) screening for lung cancer may increase overdiagnosis compared to no screening, though the risk is likely low versus chest X‐ray. Our review of 8 trials (84 660 participants) shows added costs. Further research with strict adherence to modern nodule management strategies may help determine the extent to which ...
Fiorella Karina Fernández‐Sáenz, Laura de la Torre‐Perez, David R Baldwin, Carlijn van der Aalst, Mangesh Thorat, David Ritchie, Andre L Carvalho, Carolina Espina, Ivan Solà, Carlos Canelo‐Aybar, Moira Magdalena Pissinis, Pablo Alonso‐Coello, Ana Carolina Pereira Nunes Pinto   +12 more
wiley   +1 more source

Econometric estimation of country-specific hospital costs

Cost Effectiveness and Resource Allocation, 2003
Information on the unit cost of inpatient and outpatient care is an essential element for costing, budgeting and economic-evaluation exercises. Many countries lack reliable estimates, however.
Murray Christopher JL, Evans David B, Adam Taghreed   +2 more
doaj   +1 more source

Cost-effectiveness of financial incentives for smoking cessation in pregnancy [PDF]

, 2016
No abstract ...
Bauld, Linda, Boyd, Kathleen, Tappin, David M.   +2 more
core   +1 more source

Cost-effectiveness of neoadjuvant pembrolizumab plus chemotherapy with adjuvant pembrolizumab for early-stage non-small cell lung cancer in the United States [PDF]

, 2023
Wentao Tian, Lishui Niu, Ziqi Wang, Ruoyu Lu, Gang Xiao, Fuxing Deng, Guilong Tanzhu, Rongrong Zhou   +7 more
openalex   +1 more source

Liquid biopsy epigenetics: establishing a molecular profile based on cell‐free DNA

Molecular Oncology, EarlyView.
Cell‐free DNA (cfDNA) fragments in plasma from cancer patients carry epigenetic signatures reflecting their cells of origin. These epigenetic features include DNA methylation, nucleosome modifications, and variations in fragmentation. This review describes the biological properties of each feature and explores optimal strategies for harnessing cfDNA ...
Christoffer Trier Maansson, Anders Lade Nielsen, Boe Sandahl Sorensen   +2 more
wiley   +1 more source

Biosimilar medicines and cost-effectiveness

ClinicoEconomics and Outcomes Research, 2011
Steven SimoensResearch Centre for Pharmaceutical Care and Pharmaco-economics, Faculty of Pharmaceutical Sciences, Katholieke Universiteit Leuven, Leuven, BelgiumAbstract: Given that biosimilars are agents that are similar but not identical to the ...
Steven Simoens
doaj